Research programme: epigenetic editors - Chroma Medicine
Latest Information Update: 14 Nov 2023
At a glance
- Originator Chroma Medicine
- Class Antihyperlipidaemics; Antivirals
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiovascular disorders; Hepatitis B; Unspecified
Most Recent Events
- 11 Nov 2023 Pharmacodynamics data from a preclinical trial in cardiovascular disorders released by Chroma Medicine
- 20 Sep 2023 Preclinical trials in Hepatitis B in USA (unspecified route) before September 2023
- 20 Sep 2023 Pharmacodynamics data from a preclinical trial in Hepatitis B released by Chroma Medicine